35941 |
Multidisciplinary Sciences |
Prognostic value of SUVmax on 18F-fluorodeoxyglucose PET/CT scan in pa... |
PLoS One 2020 10.1371/journal.pone.0229299 |
안명주 |
2020 |
35940 |
Otorhinolaryngology; Surgery |
Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases wi... |
HEAD NECK-J SCI SPEC 2020 10.1002/hed.26067 |
안명주 |
2020 |
35939 |
Oncology |
Outstanding clinical efficacy of PD-1/PD-L1 inhibitors for pulmonary p... |
EUR J CANCER 2020 10.1016/j.ejca.2020.03.029 |
안명주 |
2020 |
35938 |
Oncology |
Osimertinib plus savolitinib in patients with EGFR mutation-positive, ... |
LANCET ONCOL 2020 10.1016/S1470-2045(19)30785-5 |
안명주 |
2020 |
35937 |
Ophthalmology |
Markedly increased ocular side effect causing severe vision deteriorat... |
BMC OPHTHALMOL 2020 10.1186/s12886-019-1285-9 |
안명주 |
2020 |
35936 |
Pathology |
Junction Location Identifier (JuLI) Accurate Detection of DNA Fusions ... |
J MOL DIAGN 2020 10.1016/j.jmoldx.2019.10.015 |
안명주 |
2020 |
35935 |
Respiratory System |
Impact of diffusing lung capacity before and after neoadjuvant concurr... |
RESP RES 2020 10.1186/s12931-019-1254-0 |
안명주 |
2020 |
35934 |
Oncology; Dentistry, Oral Surgery & Medicine |
Global treatment patterns and outcomes among patients with recurrent a... |
ORAL ONCOL 2020 10.1016/j.oraloncology.2019.104526 |
안명주 |
2020 |
35933 |
Oncology |
Genomic landscape of acquired resistance to third-generation EGFR tyro... |
CANCER 2020 10.1002/cncr.32809 |
안명주 |
2020 |
35932 |
Oncology |
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integr... |
LANCET ONCOL 2020 10.1016/S1470-2045(19)30690-4 |
안명주 |
2020 |